AJP Legacy Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol 194: 573-580, 1958;
0002-9513/58 $5.00
This Article
Right arrow Full Text (PDF)
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Whalen, W. J.
Right arrow Articles by Erickson, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Whalen, W. J.
Right arrow Articles by Erickson, R.

Nature of the Potentiating Substance in Cardiac Muscle

William J. Whalen 1, Noel Fishman 1, and Rudolph Erickson 1

1 From the Department of Physiology, School of Medicine, University of California at Los Angeles, Los Angeles, California

An extrasystole, rest, an increase in frequency, or above threshold stimulation with mass electrodes all potentiated the contractions of isolated cat papillary muscle and atrial appendage (but not strips from the posterior wall of the atria). The augmentation diminished or disappeared after the strips had been several days in the bath, after large doses of dibenamine, and after degeneration of the sympathetic nerve supply to the heart. In general, the augmentation phenomena were affected to about the same degree, which suggests a common mechanism. The results are consistent with our working hypothesis that all of the augmentation phenomena are due to intracardiac liberation of norepinephrine during each contraction, possibly from nerve endings. Evidence is presented that acetylcholine is released during activity in the cat papillary muscle as well as in the atria, and that the positive inotropic action of acetylcholine is probably due to the subsequent release of norepinephrine. Acetylcholine is apparently not a requisite for potentiation, however. The relative amounts of norepinephrine and acetylcholine liberated may determine whether augmentation or depression of contractility will be manifested.

Submitted on January 22, 1958




This article has been cited by other articles:


Home page
ScienceHome page
W. C. LEE and F. E. SHIDEMAN
Role of Myocardial Catecholamines in Cardiac Contractility
Science, April 10, 1959; 129(3354): 967 - 968.
[Abstract] [PDF]


Home page
ScienceHome page
R. F. FURCHGOTT, T. DE GUBAREFF, and A. GROSSMAN
Release of Autonomic Mediators in Cardiac Tissue by Suprathreshold Stimulation
Science, February 6, 1959; 129(3345): 328 - 329.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 1958 by the American Physiological Society.